RIGEL PHARMACEUTICALS, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2013
Total Assets: $226.1M
Liabilities Breakdown FY2013
Total Liabilities: $17.8M
Asset Breakdown
Total Assets: $226.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $20.9M | 9.2% |
| Accounts Receivable | $5.8M | 2.5% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $4.5M | 2.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $195.0M | 86.3% |
Liabilities Breakdown
Total Liabilities: $17.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.9M | 21.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $13.9M | 78.1% |